C70 Malignant neoplasm of meninges - analogs
| Description «C70 Malignant neoplasm of meninges» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 30% Compare C71.0 Malignant neoplasm, cerebrum, except lobes and ventricles
- 30% Compare C71.5 Malignant neoplasm, cerebral ventricle
- 30% Compare C70.9 Malignant neoplasm, meninges, unspecified
- 23% Compare C71.7 Malignant neoplasm, brain stem
- 18% Compare C70.1 Malignant neoplasm, spinal meninges
- 15% Compare C71.9 Malignant neoplasm, brain, unspecified
- 15% Compare C71 Malignant neoplasm of brain
- 15% Compare C71.8 Malignant neoplasm, overlapping lesion of brain
- 15% Compare C70.0 Malignant neoplasm, cerebral meninges
- 15% Compare C72.8 Malignant neoplasm, overlapping lesion of brain and other parts of central nervous system
- 15% Compare C69-C72 Malignant neoplasms of the eye, brain and other parts of the central nervous system
- 15% Compare C79.3 Secondary malignant neoplasm of brain and cerebral meninges
- 12% Compare C72.5 Malignant neoplasm, other and unspecified cranial nerves
- 11% Compare C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
- 10% Compare C93.0 Acute monoblastic/monocytic leukaemia
- 10% Compare D13.4 Benign neoplasm, liver
- 10% Compare C34.1 Malignant neoplasm, upper lobe, bronchus or lung
- 10% Compare C34.9 Malignant neoplasm, bronchus or lung, unspecified
- 10% Compare E88.3 Tumour lysis syndrome
- 10% Compare C22.0 Malignant neoplasm, liver cell carcinoma
- 10% Compare C67.9 Malignant neoplasm, bladder, unspecified
- 10% Compare C54.1 Malignant neoplasm, endometrium
- 10% Compare C51.9 Malignant neoplasm, vulva, unspecified
- 10% Compare C77 Secondary and unspecified malignant neoplasm of lymph nodes
- 10% Compare C18.3 Malignant neoplasm, hepatic flexure
- 10% Compare D33.0 Benign neoplasm, brain, supratentorial
- 10% Compare D29.0 Benign neoplasm, penis
- 10% Compare C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
- 10% Compare C92.5 Acute myelomonocytic leukaemia
- 10% Compare C30.0 Malignant neoplasm, nasal cavity
- 10% Compare C91.9 Lymphoid leukaemia, unspecified
- 10% Compare D33.1 Benign neoplasm, brain, infratentorial
- 10% Compare C15.5 Malignant neoplasm, lower third of oesophagus
- 10% Compare C15.4 Malignant neoplasm, middle third of oesophagus
- 10% Compare D33.4 Benign neoplasm, spinal cord
- 10% Compare C67 Malignant neoplasm of bladder
- 10% Compare D33 Benign neoplasm of brain and other parts of central nervous system
- 10% Compare C76-C80 Malignant neoplasms of inaccurately designated, secondary and unspecified localizations
- 10% Compare C92.4 Acute promyelocytic leukaemia [PML]
- 10% Compare C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
- 10% Compare D33.2 Benign neoplasm, brain, unspecified
- 10% Compare C94 Other leukaemias of specified cell type
- 10% Compare C38.1 Malignant neoplasm, anterior mediastinum
- 10% Compare C24.0 Malignant neoplasm, extrahepatic bile duct
- 10% Compare C10 Malignant neoplasm of oropharynx
- 10% Compare C94.2 Acute megakaryoblastic leukaemia
- 10% Compare C38.3 Malignant neoplasm, mediastinum, part unspecified
- 10% Compare C95.0 Acute leukaemia of unspecified cell type
- 10% Compare C41.4 Malignant neoplasm, pelvic bones, sacrum and coccyx
- 10% Compare C41.0 Malignant neoplasm, bones of skull and face
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnostics.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.